(Z)-2-(2-(2-methoxy-5-(3,4,5-trimethoxystyryl)phenoxy)propan-2-yl)-5-nitrothiophene

ID: ALA4094475

Chembl Id: CHEMBL4094475

PubChem CID: 11752085

Max Phase: Preclinical

Molecular Formula: C25H27NO7S

Molecular Weight: 485.56

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OC(C)(C)c1ccc([N+](=O)[O-])s1

Standard InChI:  InChI=1S/C25H27NO7S/c1-25(2,22-11-12-23(34-22)26(27)28)33-19-13-16(9-10-18(19)29-3)7-8-17-14-20(30-4)24(32-6)21(15-17)31-5/h7-15H,1-6H3/b8-7-

Standard InChI Key:  WZSKVKFBTMLUAY-FPLPWBNLSA-N

Associated Targets(Human)

POR Tbio NADPH--cytochrome P450 reductase (112 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TUBB4B Tclin Tubulin (5180 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Por NADPH--cytochrome P450 reductase (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
4T1 (1737 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 485.56Molecular Weight (Monoisotopic): 485.1508AlogP: 6.18#Rotatable Bonds: 10
Polar Surface Area: 89.29Molecular Species: NEUTRALHBA: 8HBD:
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.97CX LogD: 5.97
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.19Np Likeness Score: -0.27

References

1. Winn BA, Shi Z, Carlson GJ, Wang Y, Nguyen BL, Kelly EM, Ross RD, Hamel E, Chaplin DJ, Trawick ML, Pinney KG..  (2017)  Bioreductively activatable prodrug conjugates of phenstatin designed to target tumor hypoxia.,  27  (3): [PMID:28007448] [10.1016/j.bmcl.2016.11.093]
2. Winn BA, Devkota L, Kuch B, MacDonough MT, Strecker TE, Wang Y, Shi Z, Gerberich JL, Mondal D, Ramirez AJ, Hamel E, Chaplin DJ, Davis P, Mason RP, Trawick ML, Pinney KG..  (2020)  Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia.,  83  (4): [PMID:32196334] [10.1021/acs.jnatprod.9b00773]

Source